These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36743918)

  • 1. Commentary: Is there a role for diabetes-specific nutrition formulas as meal replacements in type 2 diabetes?
    Glenn AJ; Liu S
    Front Endocrinol (Lausanne); 2022; 13():1094954. PubMed ID: 36743918
    [No Abstract]   [Full Text] [Related]  

  • 2. Do meal replacement drinks have a role in diabetes management?
    Ditschuneit HH
    Nestle Nutr Workshop Ser Clin Perform Programme; 2006; 11():171-181. PubMed ID: 16820739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meal Replacements Are They for You?
    Campbell A
    Diabetes Self Manag; 2017 May; 34(3):66-69. PubMed ID: 29714852
    [No Abstract]   [Full Text] [Related]  

  • 4. The Effect of Liquid Meal Replacements on Cardiometabolic Risk Factors in Overweight/Obese Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Noronha JC; Nishi SK; Braunstein CR; Khan TA; Blanco Mejia S; Kendall CWC; Kahleová H; Rahelić D; Salas-Salvadó J; Leiter LA; Sievenpiper JL
    Diabetes Care; 2019 May; 42(5):767-776. PubMed ID: 30923163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Diabetes-Specific Nutritional Formulas versus Oatmeal on Postprandial Glucose, Insulin, GLP-1 and Postprandial Lipidemia.
    Mottalib A; Mohd-Yusof BN; Shehabeldin M; Pober DM; Mitri J; Hamdy O
    Nutrients; 2016 Jul; 8(7):. PubMed ID: 27455318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary treatment and long-term weight loss and maintenance in type 2 diabetes.
    Hensrud DD
    Obes Res; 2001 Nov; 9 Suppl 4():348S-353S. PubMed ID: 11707564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meal replacement reduces insulin requirement, HbA1c and weight long-term in type 2 diabetes patients with >100 U insulin per day.
    Kempf K; Schloot NC; Gärtner B; Keil R; Schadewaldt P; Martin S
    J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():21-7. PubMed ID: 23909831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of meal replacements in obesity treatment.
    Keogh JB; Clifton PM
    Obes Rev; 2005 Aug; 6(3):229-34. PubMed ID: 16045638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is There a Role for Diabetes-Specific Nutrition Formulas as Meal Replacements in Type 2 Diabetes?
    Noronha JC; Mechanick JI
    Front Endocrinol (Lausanne); 2022; 13():874968. PubMed ID: 35573987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Two Meal Replacement strategies on Cardiovascular Risk Parameters in Advanced Age Patients with Obesity and Osteoarthritis.
    López-Gómez JJ; Izaola-Jauregui O; Primo-Martín D; Torres-Torres B; Gómez-Hoyos E; Ortolá-Buigues A; Martín-Ferrero MA; De Luis-Román DA
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32244696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight management using a meal replacement strategy in type 2 diabetes.
    Hamdy O; Zwiefelhofer D
    Curr Diab Rep; 2010 Apr; 10(2):159-64. PubMed ID: 20425576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-enriched meal replacements do not adversely affect liver, kidney or bone density: an outpatient randomized controlled trial.
    Li Z; Treyzon L; Chen S; Yan E; Thames G; Carpenter CL
    Nutr J; 2010 Dec; 9():72. PubMed ID: 21194471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review of Recent Findings on Meal Sequence: An Attractive Dietary Approach to Prevention and Management of Type 2 Diabetes.
    Kubota S; Liu Y; Iizuka K; Kuwata H; Seino Y; Yabe D
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32825124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients.
    Early JL; Apovian CM; Aronne LJ; Fernstrom MH; Frank A; Greenway FL; Heber D; Kushner RF; Cwik KM; Walch JK; Hewkin AC; Blakesley V
    Obesity (Silver Spring); 2007 Jun; 15(6):1464-72. PubMed ID: 17557984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutrient adequacy during weight loss interventions: a randomized study in women comparing the dietary intake in a meal replacement group with a traditional food group.
    Ashley JM; Herzog H; Clodfelter S; Bovee V; Schrage J; Pritsos C
    Nutr J; 2007 Jun; 6():12. PubMed ID: 17592648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein.
    Li Z; Hong K; Saltsman P; DeShields S; Bellman M; Thames G; Liu Y; Wang HJ; Elashoff R; Heber D
    Eur J Clin Nutr; 2005 Mar; 59(3):411-8. PubMed ID: 15674301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VLCD for weight loss and remission of type 2 diabetes?
    Ahmad N; Alfaris N
    Lancet; 2018 Oct; 392(10155):1306-1307. PubMed ID: 30322573
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic and weight loss effects of long-term dietary intervention in obese patients: four-year results.
    Flechtner-Mors M; Ditschuneit HH; Johnson TD; Suchard MA; Adler G
    Obes Res; 2000 Aug; 8(5):399-402. PubMed ID: 10968732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VLCD for weight loss and remission of type 2 diabetes? - Authors' reply.
    Taylor R; Adamson AJ; Sattar N; Lean MEJ; Mathers JC;
    Lancet; 2018 Oct; 392(10155):1307. PubMed ID: 30322575
    [No Abstract]   [Full Text] [Related]  

  • 20. Liquid meal replacements and glycemic control in obese type 2 diabetes patients.
    Yip I; Go VL; DeShields S; Saltsman P; Bellman M; Thames G; Murray S; Wang HJ; Elashoff R; Heber D
    Obes Res; 2001 Nov; 9 Suppl 4():341S-347S. PubMed ID: 11707563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.